Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Hematol Oncol Clin North Am. 2010 Oct 15;24(6):1089–1107. doi: 10.1016/j.hoc.2010.08.003

Fig.3. Potential effects of Hepcidin agonists or activators on iron absorption under normal and β-thalassemic conditions.

Fig.3

Lines ending with an arrow indicate activation. Lines ending with a line indicate repression.